Skip to content

Transitional Care Interventions for Patients With Cirrhosis Post-TIPS

Transitional Care Interventions Post-TIPS

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02877953
Enrollment
76
Registered
2016-08-24
Start date
2013-01-31
Completion date
Unknown
Last updated
2016-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibrosis

Brief summary

The investigators conducted a randomized controlled trial to describe if multidisciplinary and patient-centered transitional care interventions for patients with cirrhosis post-TIPS can improve compliance behavior and reduce complications post-TIPS after discharge.

Interventions

BEHAVIORALthe prevention of complications post-TIPS

Continuous nursing through telephone follow-up, family visits, and WeChat guided patients to prevent gastrointestinal bleeding, infection and constipation ,intake quality low-protein diet, recognize minimal encephalopathy, monitor blood ammonia, return visit regularly, deal with adverse drug reactions of anticoagulant.

Sponsors

Shihezi University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of diagnosis of cirrhosis; * Child-Pugh Score \<10; * Informed Consent.

Exclusion criteria

* Age \<18 years; * Right ventricular failure; * Severe systemic infection; * Hepatocellular carcinoma (HCC); * Terminal disease; and * Failure to provide written consent to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
The compliance behavior associated with complications post-TIPS1 and 3 months after dischargeIt was surveyed using a self-designed questionnaire based on evidence. The questionnaire includes 6 items that address taking medicine on time, quality low-protein diet intake, going to sleep at a regular time, moderate exercise, emotion regulation, regular follow-up. Item responses are on a 4-point scale (0 = never to 3 = always). Data were collected by face-to-face interviews with trained transition nurses. Change is being assessed

Secondary

MeasureTime frameDescription
incidence of adverse events (shunt dysfunction and hepatic encephalopathy)1 and 3 months after dischargeChange is being assessed
Child-Pugh scoresBaseline, 1 and 3 months after dischargeChange is being assessed
Blood ammonia levelsBaseline, 1 and 3 months after dischargeChange is being assessed

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026